Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

4,122.00p
   
  • Change Today:
    -70.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 4,122.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 121,824
  • Market Cap: £2,711.04m
  • RiskGrade: 128
  • Beta: 0.05

Latest ShareCast News

Director dealings: Genus chairman makes share purchase

By Iain Gilbert

Date: Thursday 25 Nov 2021

(Sharecast News) - Genus revealed on Thursday that chairman Iain Ferguson had acquired 1,000 ordinary shares in the FTSE 250-listed biotechnology firm.

Genus sees FY profit 'moderately' below its expectations

By Michele Maatouk

Date: Wednesday 24 Nov 2021

(Sharecast News) - Animal genetics company Genus said on Wednesday that based on current trading, especially in China, pre-tax profit for 2022 is set to be "moderately lower" than its previous expectations.

Genus posts rise in FY profits but warns over hit to growth

By Michele Maatouk

Date: Thursday 09 Sep 2021

(Sharecast News) - Animal genetics company Genus reported a jump in full-year profit and revenue on Thursday as it continued to win new customers, with growth in both of its business, but warned that recent volatility in the Chinese porcine market will dent growth.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 4,122.00p
Change Today -70.00p
% Change -1.67 %
52 Week High 6,070.00
52 Week Low 4,122.00
Volume 121,824
Shares Issued 65.77m
Market Cap £2,711.04m
Beta 0.05
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.66% below the market average96.66% below the market average96.66% below the market average96.66% below the market average96.66% below the market average
95.92% below the sector average95.92% below the sector average95.92% below the sector average95.92% below the sector average95.92% below the sector average
Price Trend
29.82% below the market average29.82% below the market average29.82% below the market average29.82% below the market average29.82% below the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average
Income
88.48% below the market average88.48% below the market average88.48% below the market average88.48% below the market average88.48% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Growth
80.43% above the market average80.43% above the market average80.43% above the market average80.43% above the market average80.43% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 2
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Nov-21 04-Mar-21
Paid 10-Dec-21 01-Apr-21
Amount 21.70p 10.30p

Trades for 14-Jan-2022

Time Volume / Share Price
16:35 31,387 @ 4,122.00p
16:29 1 @ 4,146.00p
16:29 8 @ 4,146.00p
16:29 21 @ 4,144.00p
16:29 24 @ 4,144.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page